Flublok Quadrivalent Description
Flublok is a recombinant influenza vaccine.
For 2020-2021, cell- or recombinant-based vaccines are recommended to contain:
- A/Hawaii/70/2019 (H1N1)pdm09-like virus (updated)
- A/Hong Kong/45/2019 (H3N2)-like virus (updated)
- B/Washington/02/2019 (B/Victoria lineage)-like virus (updated)
- B/Phuket/3073/2013-like (Yamagata lineage) virus
Flublok is made without the use of eggs and therefore is not subject to the mutations that are sometimes introduced into the vaccine during the process of egg adaptation that can cause the traditional vaccines to be ineffective.
Flublok Quadrivalent Indication
Flublok Quadrivalent is a vaccine given to people 18 through 64 years of age. It consists of the 4 influenza strains that have been identified for the current flu season.
Flublok Quadrivalent Dosage
Administer Flublok Quadrivalent as a single 0.5 mL dose intramuscular (IM) injection only.